IN THE SPOTLIGHT

Targeting focal adhesion kinase (FAK) in non-small cell lung cancer (NSCLC): Molecular mechanisms and combination therapeutic strategies

Targeting focal adhesion kinase (FAK) in non-small cell lung cancer (NSCLC): Molecular mechanisms and combination therapeutic strategies

Efficacy and Safety of Zongertinib in Previously Treated and Treatment-Naïve HER2-Mutant NSCLC from Beamion LUNG-1 Trial

Efficacy and Safety of Zongertinib in Previously Treated and Treatment-Naïve HER2-Mutant NSCLC from Beamion LUNG-1 Trial

Mechanistic Role of Emerging Tyrosine Kinase Inhibitors (TKIs) in HER2-Mutant NSCLC

Mechanistic Role of Emerging Tyrosine Kinase Inhibitors (TKIs) in HER2-Mutant NSCLC

Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis

Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis

Oscar Tahuahua: Do HER2-Mutant NSCLC Tumors Progressing on T-DXd Lose HER2 Dependence?

Oscar Tahuahua: Do HER2-Mutant NSCLC Tumors Progressing on T-DXd Lose HER2 Dependence?

Savolitinib/Osimertinib Extends PFS in MET-Amplified EGFR-Mutated NSCLC

Savolitinib/Osimertinib Extends PFS in MET-Amplified EGFR-Mutated NSCLC

Stephen V Liu: Insights on Acquired Resistance Mechanisms to Selective RET Inhibitors in NSCLC

Stephen V Liu: Insights on Acquired Resistance Mechanisms to Selective RET Inhibitors in NSCLC

Challenges and Limitations of Sequential MET‐TKI Therapy in METex14‐ Positive NSCLC With a Focus on Non‐ILD Toxicities: A Case Report

Challenges and Limitations of Sequential MET‐TKI Therapy in METex14‐ Positive NSCLC With a Focus on Non‐ILD Toxicities: A Case Report